Clinical Trial Update: COL-3 in Treating Patients With Progressive or Recurrent Brain Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting completion of a Phase 1/2 study of COL-3 in patients with progressive or recurrent brain tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Central Nervous System Tumor

Drugs mentioned

• COL-3 (COL-3)

Snippet

Sponsor: New Approaches to Brain Tumor Therapy Consortium | Conditions: Brain and Central Nervous System Tumors | Phase 1, Phase 2 | Status: COMPLETED